OABI Company Profile and Key Details

Q: Who are the executives of OABI?

Dr. Christel Iffland Ph.D.Senior Vice President of Antibody TechnologiesDr. Douglas S. Krafte Ph.D.Senior Vice President of Ion Channels/Transporters & Icagen Ion Channel Technology Site HeadMs. Donna Ventura CPASenior Vice President of Corporation ControllerMs. Marie-Cecile van de Lavoir D.V.M., Ph.D.Senior Vice President of Technical Operations & GeneticsMs. Cia McCaffreyVice President of People & TalentDr. Bill Harriman Ph.D.Senior Vice President of Antibody Discovery

NASDAQ : OABI

OmniAb

$5.04

0.6+13.51%

At Close 4:00 PM

61.59

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

OmniAb, Inc. (OABI) stock surged +13.51%, trading at $5.04 on NASDAQ, up from the previous close of $4.44. The stock opened at $4.47, fluctuating between $4.47 and $5.43 in the recent session.

Stock Snapshot

4.44

Prev. Close

730.66M

Market Cap

4.47

Day Low

-14

P/E Ratio

-0.36

EPS (TTM)

0.01

Cash Flow per Share

4.47

Open

144.97M

Number of Shares

5.43

Day High

70.05%

Free Float in %

3.14

Book Value

5.08M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 02, 2026	4.47	5.43	4.47	5.04	5.08M
Sep 01, 2026	4.35	4.45	4.32	4.44	1.16M
Aug 31, 2026	4.44	4.46	4.33	4.38	1.18M
Aug 28, 2026	4.54	4.58	4.42	4.47	1.3M
Aug 27, 2026	4.81	4.81	4.56	4.61	1.28M
Aug 26, 2026	4.70	4.93	4.64	4.81	1.44M
Aug 25, 2026	4.68	4.78	4.58	4.66	1.47M
Aug 24, 2026	4.40	4.71	4.20	4.71	1.94M
Aug 21, 2026	4.31	4.54	4.14	4.33	1.85M
Aug 20, 2026	4.19	4.59	4.16	4.30	2.25M
Aug 19, 2026	3.95	4.19	3.83	4.19	2.87M
Aug 18, 2026	3.84	4.19	3.79	3.92	3.24M
Aug 17, 2026	4.18	4.29	3.72	3.82	18.28M
Aug 14, 2026	3.40	3.45	3.30	3.38	553.94K
Aug 13, 2026	3.44	3.64	3.41	3.43	922.11K
Aug 12, 2026	3.39	3.49	3.34	3.42	793.42K
Aug 11, 2026	3.33	3.55	3.30	3.38	1.19M
Aug 10, 2026	3.14	3.44	2.99	3.39	1.84M
Aug 07, 2026	2.37	3.12	2.35	3.08	2.46M
Aug 06, 2026	2.04	2.27	2.04	2.24	702.52K

Contact Details

EmeryVille, CA 94608

United States

https://www.omniab.com 510 250 7800

About Company

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

Stock Peers

ARGX

26.86+2.61%

argenx SE$1,055.37 REGN

28.21+3.42%

Regeneron Pharmaceuticals, Inc.$852.03 VRTX

9.1+1.66%

Vertex Pharmaceuticals Incorporated$556.75 MDGL

8.22+1.53%

Madrigal Pharmaceuticals, Inc.$546.93 UTHR

-20.68-4.03%

United Therapeutics Corporation$492.02 KRYS

5.39+1.48%

Krystal Biotech, Inc.$369.23 ONC

3.125+0.87%

BeOne Medicines AG$361.78 PRAX

4.06+1.15%

Praxis Precision Medicines, Inc.$357.50 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

2.65+0.93%

Ligand Pharmaceuticals Incorporated$286.92

Frequently Asked Questions

What is the current OmniAb, Inc. (OABI) stock price?

OmniAb, Inc. (NASDAQ: OABI) stock price is $5.04 in the last trading session. During the trading session, OABI stock reached the peak price of $5.43 while $4.47 was the lowest point it dropped to. The percentage change in OABI stock occurred in the recent session was 13.51% while the dollar amount for the price change in OABI stock was $0.60.

OABI's industry and sector of operation?

The NASDAQ listed OABI is part of Biotechnology industry that operates in the broader Healthcare sector. OmniAb, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OABI?

Dr. Christel Iffland Ph.D.
Senior Vice President of Antibody Technologies
Dr. Douglas S. Krafte Ph.D.
Senior Vice President of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
Ms. Donna Ventura CPA
Senior Vice President of Corporation Controller
Ms. Marie-Cecile van de Lavoir D.V.M., Ph.D.
Senior Vice President of Technical Operations & Genetics
Ms. Cia McCaffrey
Vice President of People & Talent
Dr. Bill Harriman Ph.D.
Senior Vice President of Antibody Discovery

How OABI did perform over past 52-week?

OABI's closing price is 287.69% higher than its 52-week low of $1.30 where as its distance from 52-week high of $5.43 is -7.18%.

How many employees does OABI have?

Number of OABI employees currently stands at 89.

Link for OABI official website?

Official Website of OABI is: https://www.omniab.com

How do I contact OABI?

OABI could be contacted at phone 510 250 7800 and can also be accessed through its website. OABI operates from 5980 Horton Street, EmeryVille, CA 94608, United States.

How many shares of OABI are traded daily?

OABI stock volume for the day was 5.08M shares. The average number of OABI shares traded daily for last 3 months was 1.11M.

What is the market cap of OABI currently?

The market value of OABI currently stands at $730.66M with its latest stock price at $5.04 and 144.97M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	89
Beta	1.22
Sales or Revenue	$34.16M
5Y Sales Change%	1.148%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	89
Beta	1.22
Sales or Revenue	$34.16M
5Y Sales Change%	1.148%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

OABI Company Profile and Key Details

OmniAb

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook